Unosil Technologies Inc is a US based privately held R&D company focused on developing and licensing infection control technologies and technology platforms for delivering actives to skin. The company owns global rights to antimicrobial silver technology and know-how on various dermal actives delivery vehicles.

The company mission is to fight the rapidly emerging threat of antibiotic resistant pathogens to the global community by making available its technologies to partners through products development and licensing.